MOLECULAR PARTNERS N/ CH0256379097 /
2/7/2023 5:30:17 PM | Chg. +0.060 | Volume | Bid5:40:00 PM | Ask5:40:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
6.160CHF | +0.98% | 13,940 Turnover: 85,057.900 |
5.950Bid Size: 1,650 | 6.300Ask Size: 400 | 198.92 mill.CHF | 0.00% | - |
Fundamentals
FY 2021 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | -2.06 CHF | -17.93% |
EPS Diluted: | -2.06 CHF | -17.93% |
Revenues per Share: | 0.30 CHF | -4.89% |
Book Value per Share: | 3.32 CHF | -9.66% |
Cash Flow per Share: | -2.82 CHF | 183.22% |
Dividend per Share: | 0.00 CHF | - |
Total | in mill. | |
Revenues: | 9.80 CHF | 5.38% |
Net Income: | -63.80 CHF | 1.59% |
Operating Cash Flow: | -91.00 CHF | - |
Cash and Cash Equivalents: | 71.80 CHF | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | - | - |
P/S Ratio: | 20.30 | 58.72 |
P/BV ratio: | 1.85 | 5.36 |
P/CF Ratio: | -2.19 | -6.32 |
PEG: | 0.17 | - |
Earnings Yield: | -33.44% | -11.56% |
Dividend Yield: | 0.00% | 0.00% |
Market Capitalization | ||
Market Capitalization: | 198.92 mill. CHF | 575.46 mill. CHF |
Free Float Market Cap.: | 115.67 mill. CHF | 334.63 mill. CHF |
Market Cap. / Employee: | 1.22 mill. CHF | 3.53 mill. CHF |
Shares Outstanding: | 32.29 mill. |
Profitability
Gross Profit Margin: | -270.41% |
EBIT Margin: | -646.94% |
Net Profit Margin: | -651.02% |
Return on Equity: | -59.46% |
Return on Assets: | -36.94% |
Financial Strength
Liquidity I / Cash Ratio: | 153.09% |
Liquidity II / Quick Ratio: | 207.89% |
Liquidity III / Current Ratio: | 350.11% |
Debt / Equity Ratio: | 60.95% |
Dynam. Debt / Equity Ratio: | -71.87% |
Efficiency
Employees: | 163 |
Personal Expenses / Employee: | 222,699.39 CHF |
Revenues / Employee: | 60,122.70 CHF |
Net Income / Employee: | -391,411.04 CHF |
Total Assets / Employee: | 1,059,509.20 CHF |
* Fiscal Year End: | 12/31/2021 |
Accounting Standard: | IFRS |
Currency: | CHF |